nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GRIA3—nerve—Parkinson's disease	0.0352	0.0933	CbGeAlD
Lithium—GSK3B—nerve—Parkinson's disease	0.0304	0.0808	CbGeAlD
Lithium—IMPA1—forebrain—Parkinson's disease	0.0171	0.0455	CbGeAlD
Lithium—GRIA3—forebrain—Parkinson's disease	0.0146	0.0387	CbGeAlD
Lithium—IMPA1—cardiovascular system—Parkinson's disease	0.0145	0.0384	CbGeAlD
Lithium—GSK3B—embryo—Parkinson's disease	0.0143	0.0378	CbGeAlD
Lithium—GSK3B—forebrain—Parkinson's disease	0.0126	0.0335	CbGeAlD
Lithium—GSK3A—forebrain—Parkinson's disease	0.011	0.0291	CbGeAlD
Lithium—GSK3B—cardiovascular system—Parkinson's disease	0.0107	0.0283	CbGeAlD
Lithium—GRIA3—medulla oblongata—Parkinson's disease	0.0105	0.0279	CbGeAlD
Lithium—IMPA1—head—Parkinson's disease	0.00981	0.026	CbGeAlD
Lithium—GRIA3—midbrain—Parkinson's disease	0.00962	0.0255	CbGeAlD
Lithium—GRIA3—spinal cord—Parkinson's disease	0.00939	0.0249	CbGeAlD
Lithium—IMPA1—nervous system—Parkinson's disease	0.0093	0.0247	CbGeAlD
Lithium—GSK3A—cardiovascular system—Parkinson's disease	0.00927	0.0246	CbGeAlD
Lithium—GSK3B—medulla oblongata—Parkinson's disease	0.00911	0.0242	CbGeAlD
Lithium—IMPA1—central nervous system—Parkinson's disease	0.00896	0.0238	CbGeAlD
Lithium—GRIA3—head—Parkinson's disease	0.00834	0.0221	CbGeAlD
Lithium—GSK3B—spinal cord—Parkinson's disease	0.00813	0.0216	CbGeAlD
Lithium—GSK3A—medulla oblongata—Parkinson's disease	0.00792	0.021	CbGeAlD
Lithium—GRIA3—nervous system—Parkinson's disease	0.00791	0.021	CbGeAlD
Lithium—GRIA3—central nervous system—Parkinson's disease	0.00761	0.0202	CbGeAlD
Lithium—GRIA3—cerebellum—Parkinson's disease	0.00744	0.0197	CbGeAlD
Lithium—GSK3A—midbrain—Parkinson's disease	0.00724	0.0192	CbGeAlD
Lithium—GSK3B—head—Parkinson's disease	0.00722	0.0192	CbGeAlD
Lithium—IMPA1—brain—Parkinson's disease	0.00711	0.0189	CbGeAlD
Lithium—GSK3A—spinal cord—Parkinson's disease	0.00707	0.0187	CbGeAlD
Lithium—GSK3B—nervous system—Parkinson's disease	0.00685	0.0182	CbGeAlD
Lithium—GSK3B—central nervous system—Parkinson's disease	0.00659	0.0175	CbGeAlD
Lithium—GSK3B—cerebellum—Parkinson's disease	0.00644	0.0171	CbGeAlD
Lithium—GSK3A—head—Parkinson's disease	0.00628	0.0167	CbGeAlD
Lithium—GRIA3—brain—Parkinson's disease	0.00605	0.016	CbGeAlD
Lithium—GSK3A—nervous system—Parkinson's disease	0.00595	0.0158	CbGeAlD
Lithium—GSK3A—central nervous system—Parkinson's disease	0.00573	0.0152	CbGeAlD
Lithium—GSK3A—cerebellum—Parkinson's disease	0.0056	0.0149	CbGeAlD
Lithium—IMPA2—brain—Parkinson's disease	0.00534	0.0142	CbGeAlD
Lithium—GSK3B—brain—Parkinson's disease	0.00523	0.0139	CbGeAlD
Lithium—GSK3A—brain—Parkinson's disease	0.00455	0.0121	CbGeAlD
Lithium—IMPA2—Metabolism—NQO1—Parkinson's disease	0.000585	0.000939	CbGpPWpGaD
Lithium—IMPA2—Metabolism—TH—Parkinson's disease	0.000577	0.000926	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CYP2D6—Parkinson's disease	0.000577	0.000926	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—PARK2—Parkinson's disease	0.000574	0.000922	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—CYCS—Parkinson's disease	0.00057	0.000915	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—FGF20—Parkinson's disease	0.00057	0.000914	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CTGF—Parkinson's disease	0.000566	0.000909	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—MAPK8—Parkinson's disease	0.000566	0.000908	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—ADRBK1—Parkinson's disease	0.000565	0.000907	CbGpPWpGaD
Lithium—GSK3A—Disease—FBP1—Parkinson's disease	0.000565	0.000906	CbGpPWpGaD
Lithium—GSK3A—Disease—TAF1—Parkinson's disease	0.000565	0.000906	CbGpPWpGaD
Lithium—GSK3B—Corticotropin-releasing hormone—CASP3—Parkinson's disease	0.000561	0.000901	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—VPS35—Parkinson's disease	0.000561	0.000901	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—HSPA8—Parkinson's disease	0.000557	0.000895	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—RPL23A—Parkinson's disease	0.000556	0.000892	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—RPL14—Parkinson's disease	0.000556	0.000892	CbGpPWpGaD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—MAPK8—Parkinson's disease	0.000555	0.000891	CbGpPWpGaD
Lithium—IMPA2—Metabolism—CYCS—Parkinson's disease	0.000554	0.000889	CbGpPWpGaD
Lithium—GSK3B—Disease—MCCC1—Parkinson's disease	0.000551	0.000884	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—NGF—Parkinson's disease	0.000545	0.000874	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CYP2E1—Parkinson's disease	0.000527	0.000847	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—NGF—Parkinson's disease	0.000523	0.00084	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—DLG4—Parkinson's disease	0.000523	0.000839	CbGpPWpGaD
Lithium—IMPA1—Metabolism—NQO1—Parkinson's disease	0.000522	0.000837	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—RPS8—Parkinson's disease	0.000518	0.000832	CbGpPWpGaD
Lithium—GSK3B—Disease—TALDO1—Parkinson's disease	0.000518	0.000831	CbGpPWpGaD
Lithium—GSK3B—Disease—OMD—Parkinson's disease	0.000518	0.000831	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—DCTN1—Parkinson's disease	0.000516	0.000829	CbGpPWpGaD
Lithium—GSK3B—Corticotropin-releasing hormone—MAPK8—Parkinson's disease	0.000516	0.000828	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—SOD1—Parkinson's disease	0.000515	0.000826	CbGpPWpGaD
Lithium—IMPA1—Metabolism—TH—Parkinson's disease	0.000514	0.000825	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—GRIN2B—Parkinson's disease	0.000511	0.00082	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.000511	0.00082	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL1B—Parkinson's disease	0.000506	0.000812	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—GSTP1—Parkinson's disease	0.000502	0.000806	CbGpPWpGaD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—MAPK8—Parkinson's disease	0.000495	0.000794	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CYCS—Parkinson's disease	0.000494	0.000792	CbGpPWpGaD
Lithium—IMPA2—Metabolism—COMT—Parkinson's disease	0.00049	0.000787	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GSTP1—Parkinson's disease	0.000488	0.000783	CbGpPWpGaD
Lithium—IMPA2—Metabolism—MAOA—Parkinson's disease	0.000487	0.000781	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—PLA2G6—Parkinson's disease	0.000484	0.000777	CbGpPWpGaD
Lithium—IMPA2—Metabolism—HMOX1—Parkinson's disease	0.000481	0.000773	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-DRA—Parkinson's disease	0.00047	0.000754	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DGKQ—Parkinson's disease	0.000465	0.000746	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GPR37—Parkinson's disease	0.000465	0.000746	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—SOD2—Parkinson's disease	0.000463	0.000744	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ABCB1—Parkinson's disease	0.000462	0.000741	CbGpPWpGaD
Lithium—GSK3B—Alzheimers Disease—TNF—Parkinson's disease	0.000461	0.00074	CbGpPWpGaD
Lithium—GSK3A—Disease—RPL6—Parkinson's disease	0.000451	0.000724	CbGpPWpGaD
Lithium—GSK3A—Disease—SNCA—Parkinson's disease	0.000451	0.000724	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—MAPK8—Parkinson's disease	0.00045	0.000723	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GSTM1—Parkinson's disease	0.000449	0.00072	CbGpPWpGaD
Lithium—GSK3A—Insulin Signaling—MAPK8—Parkinson's disease	0.000448	0.00072	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—GPX1—Parkinson's disease	0.000442	0.000709	CbGpPWpGaD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—TNF—Parkinson's disease	0.000439	0.000705	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGF20—Parkinson's disease	0.000438	0.000704	CbGpPWpGaD
Lithium—IMPA1—Metabolism—COMT—Parkinson's disease	0.000437	0.000701	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—ADRBK1—Parkinson's disease	0.000436	0.0007	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GSTP1—Parkinson's disease	0.000435	0.000698	CbGpPWpGaD
Lithium—IMPA1—Metabolism—MAOA—Parkinson's disease	0.000434	0.000697	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GPX1—Parkinson's disease	0.00043	0.000689	CbGpPWpGaD
Lithium—IMPA1—Metabolism—HMOX1—Parkinson's disease	0.000429	0.000689	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000425	0.000683	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PARK2—Parkinson's disease	0.000424	0.000681	CbGpPWpGaD
Lithium—GSK3A—Immune System—DCTN1—Parkinson's disease	0.000424	0.00068	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000423	0.00068	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGF20—Parkinson's disease	0.000421	0.000676	CbGpPWpGaD
Lithium—GSK3B—Disease—TAF1—Parkinson's disease	0.000417	0.00067	CbGpPWpGaD
Lithium—GSK3B—Disease—FBP1—Parkinson's disease	0.000417	0.00067	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—ABL1—Parkinson's disease	0.000417	0.000669	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—VPS35—Parkinson's disease	0.000415	0.000666	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—MAPK8—Parkinson's disease	0.000414	0.000664	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ABCB1—Parkinson's disease	0.000412	0.000661	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—NGF—Parkinson's disease	0.000402	0.000646	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GSTM1—Parkinson's disease	0.0004	0.000642	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—HSPA8—Parkinson's disease	0.000398	0.000638	CbGpPWpGaD
Lithium—IMPA2—Metabolism—MTHFR—Parkinson's disease	0.000396	0.000636	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—CASP3—Parkinson's disease	0.000392	0.00063	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000389	0.000625	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-DRA—Parkinson's disease	0.000386	0.000619	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GPX1—Parkinson's disease	0.000383	0.000614	CbGpPWpGaD
Lithium—GSK3A—Immune System—PLA2G6—Parkinson's disease	0.000382	0.000613	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—DLG4—Parkinson's disease	0.000373	0.000599	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RIT2—Parkinson's disease	0.000372	0.000597	CbGpPWpGaD
Lithium—IMPA2—Metabolism—APOE—Parkinson's disease	0.000369	0.000592	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—GRIN2B—Parkinson's disease	0.000365	0.000585	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL6—Parkinson's disease	0.000361	0.00058	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000361	0.000579	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—ABL1—Parkinson's disease	0.000355	0.00057	CbGpPWpGaD
Lithium—IMPA1—Metabolism—MTHFR—Parkinson's disease	0.000353	0.000567	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GRK5—Parkinson's disease	0.000352	0.000566	CbGpPWpGaD
Lithium—GSK3A—Immune System—PARK2—Parkinson's disease	0.000348	0.000559	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF20—Parkinson's disease	0.000346	0.000555	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GPR37—Parkinson's disease	0.000344	0.000551	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DGKQ—Parkinson's disease	0.000344	0.000551	CbGpPWpGaD
Lithium—GSK3A—Disease—RPL23A—Parkinson's disease	0.000342	0.000549	CbGpPWpGaD
Lithium—GSK3A—Disease—RPL14—Parkinson's disease	0.000342	0.000549	CbGpPWpGaD
Lithium—GSK3B—Disease—RPL6—Parkinson's disease	0.000334	0.000535	CbGpPWpGaD
Lithium—GSK3B—Disease—SNCA—Parkinson's disease	0.000334	0.000535	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—MAPK8—Parkinson's disease	0.000331	0.000532	CbGpPWpGaD
Lithium—IMPA1—Metabolism—APOE—Parkinson's disease	0.000329	0.000528	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—ADRBK1—Parkinson's disease	0.000322	0.000517	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF20—Parkinson's disease	0.000319	0.000512	CbGpPWpGaD
Lithium—GSK3A—Disease—RPS8—Parkinson's disease	0.000319	0.000512	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—IL6—Parkinson's disease	0.000317	0.000509	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GRM4—Parkinson's disease	0.000316	0.000507	CbGpPWpGaD
Lithium—IMPA2—Metabolism—INS—Parkinson's disease	0.000315	0.000506	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000314	0.000504	CbGpPWpGaD
Lithium—GSK3B—Immune System—DCTN1—Parkinson's disease	0.000313	0.000503	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—IGF2—Parkinson's disease	0.000309	0.000496	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000308	0.000494	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—CASP3—Parkinson's disease	0.000307	0.000492	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—MAPK8—Parkinson's disease	0.000306	0.000491	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—IL6—Parkinson's disease	0.000303	0.000487	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PENK—Parkinson's disease	0.0003	0.000481	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAG—Parkinson's disease	0.0003	0.000481	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—IL6—Parkinson's disease	0.000298	0.000479	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—ABL1—Parkinson's disease	0.000297	0.000477	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL6—Parkinson's disease	0.000296	0.000476	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—MAPK8—Parkinson's disease	0.000289	0.000464	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-DRA—Parkinson's disease	0.000285	0.000457	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—IL6—Parkinson's disease	0.000285	0.000457	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—IL6—Parkinson's disease	0.000284	0.000455	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—IL6—Parkinson's disease	0.000282	0.000453	CbGpPWpGaD
Lithium—GSK3B—Immune System—PLA2G6—Parkinson's disease	0.000282	0.000453	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—MAPK8—Parkinson's disease	0.000282	0.000452	CbGpPWpGaD
Lithium—IMPA1—Metabolism—INS—Parkinson's disease	0.000281	0.000451	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—IL6—Parkinson's disease	0.000281	0.000451	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—MAPK8—Parkinson's disease	0.000276	0.000443	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RIT2—Parkinson's disease	0.000275	0.000441	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PDYN—Parkinson's disease	0.000274	0.00044	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—IL6—Parkinson's disease	0.000264	0.000424	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—IL6—Parkinson's disease	0.000264	0.000424	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	0.000264	0.000424	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—ABL1—Parkinson's disease	0.000263	0.000422	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—IL6—Parkinson's disease	0.000262	0.00042	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GRK5—Parkinson's disease	0.00026	0.000418	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—IL6—Parkinson's disease	0.000259	0.000416	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—IL6—Parkinson's disease	0.000258	0.000415	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GFAP—Parkinson's disease	0.000258	0.000414	CbGpPWpGaD
Lithium—GSK3B—Immune System—PARK2—Parkinson's disease	0.000257	0.000413	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF20—Parkinson's disease	0.000255	0.00041	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GRM5—Parkinson's disease	0.000255	0.000409	CbGpPWpGaD
Lithium—GSK3A—Immune System—ADRBK1—Parkinson's disease	0.000254	0.000408	CbGpPWpGaD
Lithium—GSK3B—Disease—RPL23A—Parkinson's disease	0.000253	0.000406	CbGpPWpGaD
Lithium—GSK3B—Disease—RPL14—Parkinson's disease	0.000253	0.000406	CbGpPWpGaD
Lithium—GSK3B—Disease—RPS8—Parkinson's disease	0.000236	0.000378	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF20—Parkinson's disease	0.000236	0.000378	CbGpPWpGaD
Lithium—GSK3A—Disease—ADRBK1—Parkinson's disease	0.000234	0.000376	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—IL6—Parkinson's disease	0.000234	0.000376	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	0.000234	0.000375	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GRM4—Parkinson's disease	0.000234	0.000375	CbGpPWpGaD
Lithium—GSK3A—Disease—HSPA1A—Parkinson's disease	0.000233	0.000374	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—CASP3—Parkinson's disease	0.000227	0.000364	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—IL6—Parkinson's disease	0.000224	0.00036	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF20—Parkinson's disease	0.000223	0.000359	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—MAPK8—Parkinson's disease	0.000222	0.000356	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PENK—Parkinson's disease	0.000221	0.000355	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAG—Parkinson's disease	0.000221	0.000355	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—IL6—Parkinson's disease	0.00022	0.000354	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000217	0.000348	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—IL6—Parkinson's disease	0.000211	0.000338	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—IL6—Parkinson's disease	0.00021	0.000336	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—IL6—Parkinson's disease	0.000208	0.000335	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—MAPK8—Parkinson's disease	0.000208	0.000334	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—IL6—Parkinson's disease	0.000207	0.000333	CbGpPWpGaD
Lithium—GSK3A—Immune System—ABL1—Parkinson's disease	0.000207	0.000332	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—INS—Parkinson's disease	0.000205	0.000329	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PDYN—Parkinson's disease	0.000203	0.000325	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—INSR—Parkinson's disease	0.0002	0.000321	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—INS—Parkinson's disease	0.000197	0.000315	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—IL6—Parkinson's disease	0.000195	0.000313	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6—Parkinson's disease	0.000195	0.000313	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	0.000195	0.000313	CbGpPWpGaD
Lithium—GSK3A—Immune System—HGF—Parkinson's disease	0.000195	0.000312	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—IL6—Parkinson's disease	0.000193	0.00031	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6—Parkinson's disease	0.000192	0.000308	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—IL6—Parkinson's disease	0.000191	0.000306	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GFAP—Parkinson's disease	0.00019	0.000306	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGB—Parkinson's disease	0.000189	0.000303	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GRM5—Parkinson's disease	0.000188	0.000302	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR1A—Parkinson's disease	0.000188	0.000302	CbGpPWpGaD
Lithium—GSK3B—Immune System—ADRBK1—Parkinson's disease	0.000188	0.000301	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TAC1—Parkinson's disease	0.000185	0.000297	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DRD1—Parkinson's disease	0.000182	0.000291	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IL6—Parkinson's disease	0.00018	0.000289	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—IL6—Parkinson's disease	0.000176	0.000283	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DRD3—Parkinson's disease	0.000176	0.000282	CbGpPWpGaD
Lithium—GSK3B—Disease—ADRBK1—Parkinson's disease	0.000173	0.000278	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	0.000173	0.000277	CbGpPWpGaD
Lithium—GSK3B—Disease—HSPA1A—Parkinson's disease	0.000172	0.000276	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF20—Parkinson's disease	0.000165	0.000265	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000164	0.000264	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MAPK8—Parkinson's disease	0.000161	0.000258	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADORA2A—Parkinson's disease	0.00016	0.000257	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR7—Parkinson's disease	0.000159	0.000255	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DRD2—Parkinson's disease	0.000159	0.000255	CbGpPWpGaD
Lithium—GSK3A—Disease—MTHFR—Parkinson's disease	0.000159	0.000255	CbGpPWpGaD
Lithium—GSK3B—Immune System—ABL1—Parkinson's disease	0.000153	0.000246	CbGpPWpGaD
Lithium—GSK3A—Disease—APOE—Parkinson's disease	0.000148	0.000237	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—INSR—Parkinson's disease	0.000148	0.000237	CbGpPWpGaD
Lithium—GSK3B—Immune System—HGF—Parkinson's disease	0.000144	0.000231	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—Parkinson's disease	0.000142	0.000228	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGB—Parkinson's disease	0.00014	0.000224	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR1A—Parkinson's disease	0.000139	0.000223	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TAC1—Parkinson's disease	0.000137	0.00022	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD1—Parkinson's disease	0.000134	0.000215	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF2—Parkinson's disease	0.000133	0.000214	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—Parkinson's disease	0.000133	0.000213	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD3—Parkinson's disease	0.00013	0.000209	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1R—Parkinson's disease	0.000129	0.000207	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—EDN1—Parkinson's disease	0.000127	0.000204	CbGpPWpGaD
Lithium—GSK3A—Disease—INS—Parkinson's disease	0.000126	0.000203	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000121	0.000195	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—Parkinson's disease	0.00012	0.000193	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAPK8—Parkinson's disease	0.000119	0.000191	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR7—Parkinson's disease	0.000117	0.000189	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD2—Parkinson's disease	0.000117	0.000189	CbGpPWpGaD
Lithium—GSK3B—Disease—MTHFR—Parkinson's disease	0.000117	0.000188	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NGF—Parkinson's disease	0.000117	0.000188	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR2A—Parkinson's disease	0.000111	0.000179	CbGpPWpGaD
Lithium—GSK3B—Disease—APOE—Parkinson's disease	0.000109	0.000175	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—Parkinson's disease	0.000106	0.000171	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOE—Parkinson's disease	0.000104	0.000166	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—Parkinson's disease	0.000103	0.000165	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—Parkinson's disease	0.000102	0.000164	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF2—Parkinson's disease	9.85e-05	0.000158	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1R—Parkinson's disease	9.52e-05	0.000153	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EDN1—Parkinson's disease	9.41e-05	0.000151	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAPK8—Parkinson's disease	9.36e-05	0.00015	CbGpPWpGaD
Lithium—GSK3B—Disease—INS—Parkinson's disease	9.33e-05	0.00015	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—INS—Parkinson's disease	8.84e-05	0.000142	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NGF—Parkinson's disease	8.64e-05	0.000139	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—Parkinson's disease	8.59e-05	0.000138	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2A—Parkinson's disease	8.23e-05	0.000132	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOE—Parkinson's disease	7.65e-05	0.000123	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—Parkinson's disease	7.58e-05	0.000122	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—Parkinson's disease	7.54e-05	0.000121	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK8—Parkinson's disease	6.92e-05	0.000111	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CASP3—Parkinson's disease	6.59e-05	0.000106	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—INS—Parkinson's disease	6.54e-05	0.000105	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK8—Parkinson's disease	6.05e-05	9.71e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—Parkinson's disease	5.98e-05	9.59e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—Parkinson's disease	5.52e-05	8.86e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CASP3—Parkinson's disease	4.87e-05	7.81e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK8—Parkinson's disease	4.47e-05	7.18e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—Parkinson's disease	4.42e-05	7.09e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—Parkinson's disease	4.08e-05	6.55e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—Parkinson's disease	3.86e-05	6.2e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—Parkinson's disease	2.86e-05	4.58e-05	CbGpPWpGaD
